- Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
-
Yip TCF, Lyu F, Lin H, Li G, Yuen PC, Wong VWS, Wong GLH
- KMID: 2539799
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S171-S183.
- doi: 10.3350/cmh.2022.0426
Inflammation is the key driver of liver fibrosis progression in non-alcoholic fatty liver disease (NAFLD). Unfortunately, it is often challenging to assess inflammation in NAFLD due to its dynamic nature... -
- CITED
-
- Close
- SHARE
-
- Close
